Assenagon Asset Management S.A. Care Dx, Inc. Transaction History
Assenagon Asset Management S.A.
- $47.8 Billion
- Q3 2024
A detailed history of Assenagon Asset Management S.A. transactions in Care Dx, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 65,787 shares of CDNA stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,787
Previous 166,305
60.44%
Holding current value
$1.54 Million
Previous $2.58 Million
20.49%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$106 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$73.4 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$69.8 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$47.5 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.25B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...